These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 17367812)

  • 1. Quantification of nicotinic acetylcholine receptors in Parkinson's disease with (123)I-5IA SPECT.
    Oishi N; Hashikawa K; Yoshida H; Ishizu K; Ueda M; Kawashima H; Saji H; Fukuyama H
    J Neurol Sci; 2007 May; 256(1-2):52-60. PubMed ID: 17367812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of human nicotinic acetylcholine receptors with 123I-5IA SPECT.
    Mamede M; Ishizu K; Ueda M; Mukai T; Iida Y; Fukuyama H; Saga T; Saji H
    J Nucl Med; 2004 Sep; 45(9):1458-70. PubMed ID: 15347712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive evaluation of nicotinic acetylcholine receptor availability in mouse brain using single-photon emission computed tomography with [(123)I]5IA.
    Matsuura Y; Ueda M; Higaki Y; Watanabe K; Habara S; Kamino S; Saji H; Enomoto S
    Nucl Med Biol; 2016 Jun; 43(6):372-8. PubMed ID: 27260778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of radioiodinated 5-iodo-3-(2(S)-azetidinylmethoxy)pyridine as a ligand for SPECT investigations of brain nicotinic acetylcholine receptors.
    Saji H; Ogawa M; Ueda M; Iida Y; Magata Y; Tominaga A; Kawashima H; Kitamura Y; Nakagawa M; Kiyono Y; Mukai T
    Ann Nucl Med; 2002 May; 16(3):189-200. PubMed ID: 12126044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotinic acetylcholine receptor distribution in Alzheimer's disease, dementia with Lewy bodies, Parkinson's disease, and vascular dementia: in vitro binding study using 5-[(125)i]-a-85380.
    Pimlott SL; Piggott M; Owens J; Greally E; Court JA; Jaros E; Perry RH; Perry EK; Wyper D
    Neuropsychopharmacology; 2004 Jan; 29(1):108-16. PubMed ID: 12955099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-[123I]Iodo-A-85380: assessment of pharmacological safety, radiation dosimetry and SPECT imaging of brain nicotinic receptors in healthy human subjects.
    Ueda M; Iida Y; Mukai T; Mamede M; Ishizu K; Ogawa M; Magata Y; Konishi J; Saji H
    Ann Nucl Med; 2004 Jun; 18(4):337-44. PubMed ID: 15359928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Widespread decrease of nicotinic acetylcholine receptors in Parkinson's disease.
    Fujita M; Ichise M; Zoghbi SS; Liow JS; Ghose S; Vines DC; Sangare J; Lu JQ; Cropley VL; Iida H; Kim KM; Cohen RM; Bara-Jimenez W; Ravina B; Innis RB
    Ann Neurol; 2006 Jan; 59(1):174-7. PubMed ID: 16374823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in nicotinic α4β2 receptor binding in vascular dementia using ¹²³I-5IA-85380 SPECT: comparison with regional cerebral blood flow.
    Colloby SJ; Firbank MJ; Pakrasi S; Perry EK; Pimlott SL; Wyper DJ; McKeith IG; Williams ED; O'Brien JT
    Neurobiol Aging; 2011 Feb; 32(2):293-301. PubMed ID: 19269714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decrease of nicotinic receptors in the nigrostriatal system in Parkinson's disease.
    Kas A; Bottlaender M; Gallezot JD; Vidailhet M; Villafane G; Grégoire MC; Coulon C; Valette H; Dollé F; Ribeiro MJ; Hantraye P; Remy P
    J Cereb Blood Flow Metab; 2009 Sep; 29(9):1601-8. PubMed ID: 19491921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo relationship between thalamic nicotinic acetylcholine receptor occupancy rates and antiallodynic effects in a rat model of neuropathic pain: persistent agonist binding inhibits the expression of antiallodynic effects.
    Ueda M; Iida Y; Yoneyama T; Kawai T; Ogawa M; Magata Y; Saji H
    Synapse; 2011 Jan; 65(1):77-83. PubMed ID: 20506320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotinic alpha4beta2 receptor binding in dementia with Lewy bodies using 123I-5IA-85380 SPECT demonstrates a link between occipital changes and visual hallucinations.
    O'Brien JT; Colloby SJ; Pakrasi S; Perry EK; Pimlott SL; Wyper DJ; McKeith IG; Williams ED
    Neuroimage; 2008 Apr; 40(3):1056-63. PubMed ID: 18295510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha4beta2 nicotinic receptor status in Alzheimer's disease using 123I-5IA-85380 single-photon-emission computed tomography.
    O'Brien JT; Colloby SJ; Pakrasi S; Perry EK; Pimlott SL; Wyper DJ; McKeith IG; Williams ED
    J Neurol Neurosurg Psychiatry; 2007 Apr; 78(4):356-62. PubMed ID: 17135460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo imaging of human cerebral nicotinic acetylcholine receptors with 2-18F-fluoro-A-85380 and PET.
    Gallezot JD; Bottlaender M; Grégoire MC; Roumenov D; Deverre JR; Coulon C; Ottaviani M; Dollé F; Syrota A; Valette H
    J Nucl Med; 2005 Feb; 46(2):240-7. PubMed ID: 15695782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alteration of the in vivo nicotinic receptor density in ADNFLE patients: a PET study.
    Picard F; Bruel D; Servent D; Saba W; Fruchart-Gaillard C; Schöllhorn-Peyronneau MA; Roumenov D; Brodtkorb E; Zuberi S; Gambardella A; Steinborn B; Hufnagel A; Valette H; Bottlaender M
    Brain; 2006 Aug; 129(Pt 8):2047-60. PubMed ID: 16815873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced alpha4beta2*-nicotinic acetylcholine receptor binding and its relationship to mild cognitive and depressive symptoms in Parkinson disease.
    Meyer PM; Strecker K; Kendziorra K; Becker G; Hesse S; Woelpl D; Hensel A; Patt M; Sorger D; Wegner F; Lobsien D; Barthel H; Brust P; Gertz HJ; Sabri O; Schwarz J
    Arch Gen Psychiatry; 2009 Aug; 66(8):866-77. PubMed ID: 19652126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotinic α4β2 acetylcholine receptors and cognitive function in Parkinson's disease.
    Lorenz R; Samnick S; Dillmann U; Schiller M; Ong MF; Faßbender K; Buck A; Spiegel J
    Acta Neurol Scand; 2014 Sep; 130(3):164-71. PubMed ID: 24762290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 123I-5-IA-85380 SPECT measurement of nicotinic acetylcholine receptors in human brain by the constant infusion paradigm: feasibility and reproducibility.
    Staley JK; van Dyck CH; Weinzimmer D; Brenner E; Baldwin RM; Tamagnan GD; Riccardi P; Mitsis E; Seibyl JP
    J Nucl Med; 2005 Sep; 46(9):1466-72. PubMed ID: 16157529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotinic 123I-5IA-85380 single photon emission computed tomography as a predictor of cognitive progression in Alzheimer's disease and dementia with Lewy bodies.
    Colloby SJ; Perry EK; Pakrasi S; Pimlott SL; Wyper DJ; McKeith IG; Williams ED; O'Brien JT
    Am J Geriatr Psychiatry; 2010 Jan; 18(1):86-90. PubMed ID: 20094022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 123I-5-IA-85380 SPECT imaging of nicotinic receptors in Alzheimer disease and mild cognitive impairment.
    Mitsis EM; Reech KM; Bois F; Tamagnan GD; Macavoy MG; Seibyl JP; Staley JK; van Dyck CH
    J Nucl Med; 2009 Sep; 50(9):1455-63. PubMed ID: 19690024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simplified quantification of nicotinic receptors with 2[18F]F-A-85380 PET.
    Mitkovski S; Villemagne VL; Novakovic KE; O'Keefe G; Tochon-Danguy H; Mulligan RS; Dickinson KL; Saunder T; Gregoire MC; Bottlaender M; Dolle F; Rowe CC
    Nucl Med Biol; 2005 Aug; 32(6):585-91. PubMed ID: 16026705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.